Summary for Patients: Hydroxychloroquine Dose and Risk for Incident Retinopathy

Affiliations:

From: Melles RB, Jorge AM, Marmor MF, et al. Hydroxychloroquine dose and risk for incident retinopathy. A cohort study. Ann Intern Med. 17 January 2023. [Epub ahead of print]. doi:10.7326/M22-2453

Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.

Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.

This article was published at Annals.org on 17 January 2023.

留言 (0)

沒有登入
gif